SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : Millennium Pharmaceuticals, Inc. (MLNM)

 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  
From: former_pgs6/6/2005 5:15:08 PM
  Read Replies (1) of 3044
 
8K filed:

tem 7.01 Regulation FD Disclosure.

Millennium Pharmaceuticals, Inc. (the “Company”) is furnishing this 8-K in order to provide information about the Company’s understanding regarding certain sales data reported by IMS Health Incorporated (“IMS”), a third-party pharmaceutical information and consulting company.

While the Company typically does not comment on IMS sales data, and does not assume responsibility for the accuracy of such information, the Company has learned that sales figures initially reported by IMS for VELCADE® (bortezomib) for Injection during portions of the period from December 2004 through March 2005 may not have taken into account the Company’s transfer to a single-source open access distribution model. The Company further understands that updated VELCADE sales figures are available from IMS.

The information in this item shall not be deemed “filed” for purposes of Section 18 of the Securities Exchange Act of 1934, nor shall it be deemed incorporated by reference in any disclosure document of the Company, except as shall be expressly set forth by specific reference in such document.

(snip)

I wonder if the recent weakness has to do with IMS reporting artifically low sales as a result of this distribution model?
Report TOU ViolationShare This Post
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext